Petri Kresanov – Oxidized HDL lipids and the risk for atherosclerosis

[1]  D. Ribatti,et al.  From Lipid Retention to Immune-Mediate Inflammation and Associated Angiogenesis in the Pathogenesis of Atherosclerosis. , 2015, Journal of atherosclerosis and thrombosis.

[2]  Jennifer G. Robinson,et al.  The 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk: a new paradigm supported by more evidence. , 2015, European heart journal.

[3]  M. Kersting,et al.  Fish and rapeseed oil consumption in infants and mothers: dietary habits and determinants in a nationwide sample in Germany , 2015, European Journal of Nutrition.

[4]  A. Khera,et al.  HDL cholesterol efflux capacity and incident cardiovascular events. , 2014, The New England journal of medicine.

[5]  H. Yki-Järvinen.  Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. , 2014, The lancet. Diabetes & endocrinology.

[6]  T. Vasankari,et al.  High Density Lipoprotein Level is Negatively Associated With the Increase of Oxidized Low Density Lipoprotein Lipids After a Fatty Meal , 2014, Lipids.

[7]  N. Sattar,et al.  Non-alcoholic fatty liver disease , 2014, BMJ : British Medical Journal.

[8]  E. Niki,et al.  Involvement of free radicals and oxidative stress in NAFLD/NASH , 2013, Free radical research.

[9]  R. D'Agostino,et al.  High-density lipoproteins: a consensus statement from the National Lipid Association. , 2013, Journal of clinical lipidology.

[10]  L. Shang,et al.  Reduced Paraoxonase 1 Activity as a Marker for Severe Coronary Artery Disease , 2013, Disease markers.

[11]  A. Collinson,et al.  Red meat, dietary heme iron, and risk of type 2 diabetes: the involvement of advanced lipoxidation endproducts. , 2013, Advances in nutrition.

[12]  R. Devlieger,et al.  Postpartum weight retention in obese mothers , 2012 .

[13]  D. Tsikas,et al.  Glutathione promotes prostaglandin H synthase (cyclooxygenase)‐dependent formation of malondialdehyde and 15(S)‐8‐iso‐prostaglandin F2α , 2012, FEBS letters.

[14]  A. Baranova,et al.  Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults , 2011, Alimentary pharmacology & therapeutics.

[15]  John M. Davis,et al.  n-6 Fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials , 2010, British Journal of Nutrition.

[16]  M. Phillips,et al.  Influence of Apolipoprotein (Apo) A-I Structure on Nascent High Density Lipoprotein (HDL) Particle Size Distribution* , 2010, The Journal of Biological Chemistry.

[17]  T. Lehtimäki,et al.  Elevated plasma fibrinogen caused by inadequate alpha-linolenic acid intake can be reduced by replacing fat with canola-type rapeseed oil. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[18]  R. P. Ross,et al.  Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. , 2010, Nutrition reviews.

[19]  C. Tschöpe,et al.  High-density lipoprotein-raising strategies: update 2010. , 2010, Current pharmaceutical design.

[20]  Veikko Salomaa,et al.  Thirty-five-year trends in cardiovascular risk factors in Finland. , 2010, International journal of epidemiology.

[21]  A. Tall,et al.  Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[22]  M. Couturier,et al.  HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity: Relevance to Inflammation and Atherogenesis , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[23]  A. von Eckardstein,et al.  Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. , 2009, Endocrinology.

[24]  Reino Laatikainen,et al.  High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. , 2009, The Analyst.

[25]  J. Heinecke,et al.  HDL, lipid peroxidation, and atherosclerosis11 See referenced article, J. Lipid Res. 2009, 50: 716–722. , 2009, Journal of Lipid Research.

[26]  D. Shih,et al.  Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis? , 2008, Current opinion in lipidology.

[27]  P. Peeters,et al.  Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women. , 2008, Atherosclerosis.

[28]  A. Tall,et al.  Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins , 2008, Journal of internal medicine.

[29]  P. Barter,et al.  High-Density Lipoproteins Enhance Progenitor-Mediated Endothelium Repair in Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[30]  D. Rader,et al.  High-Density Lipoprotein Promotes Endothelial Cell Migration and Reendothelialization via Scavenger Receptor-B Type I , 2005, Circulation research.

[31]  J. Danesh,et al.  Paraoxonase polymorphisms and coronary heart disease , 2004, The Lancet.

[32]  P. Yancey,et al.  Importance of different pathways of cellular cholesterol efflux. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[33]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[34]  Jan Nilsson,et al.  Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I , 2001, Circulation.

[35]  T. Vasankari,et al.  Reduced oxidized low-density lipoprotein after weight reduction in obese premenopausal women , 2001, International Journal of Obesity.

[36]  J. Viikari,et al.  Increased Arterial Intima-Media Thickness and In Vivo LDL Oxidation in Young Men With Borderline Hypertension , 2000, Hypertension.

[37]  J. Viikari,et al.  Reduced mildly oxidized LDL in young female athletes. , 2000, Atherosclerosis.

[38]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[39]  P. Barter,et al.  Remodelling of high density lipoproteins by plasma factors. , 1999, Atherosclerosis.

[40]  J. Viikari,et al.  Large-artery elastic properties in young men : relationships to serum lipoproteins and oxidized low-density lipoproteins. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[41]  R. Stocker,et al.  Greater selective uptake by Hep G2 cells of high-density lipoprotein cholesteryl ester hydroperoxides than of unoxidized cholesteryl esters. , 1993, The Biochemical journal.

[42]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[43]  E. Voutilainen,et al.  Contents of apolipoprotein A-I, A-II and B of the human serum fractions for high-density and low-density lipoproteins prepared by common precipitation methods. , 1992, Scandinavian journal of clinical and laboratory investigation.

[44]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[45]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[46]  C. Palmeira,et al.  Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. , 2012, Free radical biology & medicine.

[47]  T. Vasankari,et al.  Reduced oxidized LDL levels after a 10-month exercise program. , 1998, Medicine and science in sports and exercise.

[48]  Thematic Review Series: High Density Lipoprotein Structure, Function, and Metabolism Cardioprotective functions of HDLs 1 , 2022 .

[49]  E. Huskisson,et al.  Anti- inflammatory, , 2022 .